A COVID-19 vaccine trial participant contracted an inflammatory syndrome that affects the spinal cord. Unsure how it is linked to AstraZeneca’s vaccine. Drugmaker Pauses Covid-19 Vaccine Trial for Safety Review Quote The pharmaceutical company AstraZeneca halted global trials of its coronavirus vaccine on Tuesday because of a serious and unexpected adverse reaction in a participant, the company said. A person familiar with the situation, and who spoke on the condition of anonymity, said that the participant had been enrolled in a Phase 2/3 trial based in the United Kingdom. The individual also said that a volunteer in the U.K. trial had been found to have transverse myelitis ... More Like This Ethical Arguments Against Mandatory Vaccination by ldhrn73 A COVID-19 Dilemma: Where are all the PPEs? by tnbutterfly - Mary, BSN, RN Fact or Fiction? Masking and CO2 Dangers by J.Adderton, BSN, MSN Pay Raises, Bonuses and Incentives: Where Are We? by J.Adderton, BSN, MSN War on Nurses by dareese, MSN, RN
Home Health Columnist / Guide NRSKarenRN, BSN, RN 11 Articles; 17,702 Posts Specializes in Vents, Telemetry, Home Care, Home infusion. Has 46 years experience. Sep 10, 2020 Bloomberg News 9/09/2020 AstraZeneca Study Halted After Spinal-Cord Issue, NIH Chief Says Quote U.S. National Institutes of Health Director Francis Collins told a Senate committee Wednesday that AstraZeneca Plc’s closely watched Covid-19 vaccine trial had been halted due to a “spinal cord problem.” ... ...Appearing before the Senate Committee on Health, Education, Labor & Pensions, Collins said that the severe adverse event in question was transverse myelitis, a neurological disorder that causes inflammation of the spinal cord. If AstraZeneca’s review finds the adverse event is related to the vaccine, all the doses already manufactured will be thrown away, Collins said.... https://www.bloomberg.com/news/articles/2020-09-09/astrazeneca-study-halted-after-spinal-cord-issue-nih-chief-says c